Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00619320 · ClinicalTrials.gov registry record · Phase 2
Reducing HIV: Safer Sex Skill Building in Pregnant Drug Abusing Women
A Phase 2 study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- Phase 2
- Development phase
- 380
- Enrollment target
NCT00619320: Completed Phase 2 study, sponsored by Virginia Commonwealth University.
NCT00619320 is a Phase 2 study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 380 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (186% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00619320, a Phase 2 study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 380 participants
- Enrollment target
Study Summary
This study will examine safer sex skills building (SSB), a targeted behavioral HIV prevention and risk reduction group intervention in two samples of pregnant drug abusing women.
Interventions
- BEHAVIORAL Safer Sex Skills Building (SSB)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 380 participants |
| Start Date | 2008-12 |
| Est. Completion | 2012-10 |
| Phase | Phase 2 |
What the finished NCT00619320 record still lists
NCT00619320 is an interventional study that assigns participants to a tested intervention. The registered 380 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (186% higher).
The record links to 0 conditions, and to 1 intervention - of which Safer Sex Skills Building (SSB) is the first listed.
NCT00619320 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00619320 about?
NCT00619320 is a clinical study titled "Reducing HIV: Safer Sex Skill Building in Pregnant Drug Abusing Women". This study will examine safer sex skills building (SSB), a targeted behavioral HIV prevention and risk reduction group intervention in two samples of pregnant drug abusing women.
What is the current status of trial NCT00619320?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 380 participants. The study started on 2008-12. Estimated completion is 2012-10.
What interventions are being tested in trial NCT00619320?
The interventions under investigation include: Safer Sex Skills Building (SSB) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00619320?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00619320's enrollment target sits among peer trials
380 111th of 2000 higher than 1,886 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04560673 · 380 participants · Phase 2
Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy
- NCT04777357 · 380 participants · Phase 3
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
- NCT04821154 · 380 participants
Persona Revision Knee System Outcomes
- NCT05102019 · 380 participants · NA
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia